Cargando…
Panacea, a semantic-enabled drug recommendations discovery framework
BACKGROUND: Personalized drug prescription can be benefited from the use of intelligent information management and sharing. International standard classifications and terminologies have been developed in order to provide unique and unambiguous information representation. Such standards can be used a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975719/ https://www.ncbi.nlm.nih.gov/pubmed/24602515 http://dx.doi.org/10.1186/2041-1480-5-13 |
_version_ | 1782310180647600128 |
---|---|
author | Doulaverakis, Charalampos Nikolaidis, George Kleontas, Athanasios Kompatsiaris, Ioannis |
author_facet | Doulaverakis, Charalampos Nikolaidis, George Kleontas, Athanasios Kompatsiaris, Ioannis |
author_sort | Doulaverakis, Charalampos |
collection | PubMed |
description | BACKGROUND: Personalized drug prescription can be benefited from the use of intelligent information management and sharing. International standard classifications and terminologies have been developed in order to provide unique and unambiguous information representation. Such standards can be used as the basis of automated decision support systems for providing drug-drug and drug-disease interaction discovery. Additionally, Semantic Web technologies have been proposed in earlier works, in order to support such systems. RESULTS: The paper presents Panacea, a semantic framework capable of offering drug-drug and drug-diseases interaction discovery. For enabling this kind of service, medical information and terminology had to be translated to ontological terms and be appropriately coupled with medical knowledge of the field. International standard classifications and terminologies, provide the backbone of the common representation of medical data while the medical knowledge of drug interactions is represented by a rule base which makes use of the aforementioned standards. Representation is based on a lightweight ontology. A layered reasoning approach is implemented where at the first layer ontological inference is used in order to discover underlying knowledge, while at the second layer a two-step rule selection strategy is followed resulting in a computationally efficient reasoning approach. Details of the system architecture are presented while also giving an outline of the difficulties that had to be overcome. CONCLUSIONS: Panacea is evaluated both in terms of quality of recommendations against real clinical data and performance. The quality recommendation gave useful insights regarding requirements for real world deployment and revealed several parameters that affected the recommendation results. Performance-wise, Panacea is compared to a previous published work by the authors, a service for drug recommendations named GalenOWL, and presents their differences in modeling and approach to the problem, while also pinpointing the advantages of Panacea. Overall, the paper presents a framework for providing an efficient drug recommendations service where Semantic Web technologies are coupled with traditional business rule engines. |
format | Online Article Text |
id | pubmed-3975719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-39757192014-04-17 Panacea, a semantic-enabled drug recommendations discovery framework Doulaverakis, Charalampos Nikolaidis, George Kleontas, Athanasios Kompatsiaris, Ioannis J Biomed Semantics Research BACKGROUND: Personalized drug prescription can be benefited from the use of intelligent information management and sharing. International standard classifications and terminologies have been developed in order to provide unique and unambiguous information representation. Such standards can be used as the basis of automated decision support systems for providing drug-drug and drug-disease interaction discovery. Additionally, Semantic Web technologies have been proposed in earlier works, in order to support such systems. RESULTS: The paper presents Panacea, a semantic framework capable of offering drug-drug and drug-diseases interaction discovery. For enabling this kind of service, medical information and terminology had to be translated to ontological terms and be appropriately coupled with medical knowledge of the field. International standard classifications and terminologies, provide the backbone of the common representation of medical data while the medical knowledge of drug interactions is represented by a rule base which makes use of the aforementioned standards. Representation is based on a lightweight ontology. A layered reasoning approach is implemented where at the first layer ontological inference is used in order to discover underlying knowledge, while at the second layer a two-step rule selection strategy is followed resulting in a computationally efficient reasoning approach. Details of the system architecture are presented while also giving an outline of the difficulties that had to be overcome. CONCLUSIONS: Panacea is evaluated both in terms of quality of recommendations against real clinical data and performance. The quality recommendation gave useful insights regarding requirements for real world deployment and revealed several parameters that affected the recommendation results. Performance-wise, Panacea is compared to a previous published work by the authors, a service for drug recommendations named GalenOWL, and presents their differences in modeling and approach to the problem, while also pinpointing the advantages of Panacea. Overall, the paper presents a framework for providing an efficient drug recommendations service where Semantic Web technologies are coupled with traditional business rule engines. BioMed Central 2014-03-06 /pmc/articles/PMC3975719/ /pubmed/24602515 http://dx.doi.org/10.1186/2041-1480-5-13 Text en Copyright © 2014 Doulaverakis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Doulaverakis, Charalampos Nikolaidis, George Kleontas, Athanasios Kompatsiaris, Ioannis Panacea, a semantic-enabled drug recommendations discovery framework |
title | Panacea, a semantic-enabled drug recommendations discovery framework |
title_full | Panacea, a semantic-enabled drug recommendations discovery framework |
title_fullStr | Panacea, a semantic-enabled drug recommendations discovery framework |
title_full_unstemmed | Panacea, a semantic-enabled drug recommendations discovery framework |
title_short | Panacea, a semantic-enabled drug recommendations discovery framework |
title_sort | panacea, a semantic-enabled drug recommendations discovery framework |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975719/ https://www.ncbi.nlm.nih.gov/pubmed/24602515 http://dx.doi.org/10.1186/2041-1480-5-13 |
work_keys_str_mv | AT doulaverakischaralampos panaceaasemanticenableddrugrecommendationsdiscoveryframework AT nikolaidisgeorge panaceaasemanticenableddrugrecommendationsdiscoveryframework AT kleontasathanasios panaceaasemanticenableddrugrecommendationsdiscoveryframework AT kompatsiarisioannis panaceaasemanticenableddrugrecommendationsdiscoveryframework |